Abstract

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, which after breast, lung and, prostate cancers, is the fourth prevalent cancer in the United States. Long non-coding RNAs (lncRNAs) have an essential role in the pathogenesis of CRC. Therefore, bioinformatics studies on lncRNAs and their target genes have potential importance as novel biomarkers. In the current study, publicly available microarray gene expression data of colorectal cancer (GSE106582) was analyzed with the Limma, Geoquery, Biobase package. Afterward, identified differentially expressed lncRNAs and their target genes were inserted into Weighted correlation network analysis (WGCNA) to obtain modules and hub genes. A total of nine differentially expressed lncRNAs (LINC01018, ITCH-IT, ITPK1-AS1, FOXP1-IT1, FAM238B, PAXIP1-AS1, ATP2B1-AS1, MIR29B2CHG, and SNHG32) were identified using microarray data analysis. The WGCNA has identified several hub genes for black (LMOD3, CDKN2AIPNL, EXO5, ZNF69, BMS1P5, METTL21A, IL17RD, MIGA1, CEP19, FKBP14), blue (CLCA1, GUCA2A, UGT2B17, DSC2, CA1, AQP8, ITLN1, BEST4, KLF4, IQCF6) and turquoise (PAFAH1B1, LMNB1, CACYBP, GLO1, PUM3, POC1A, ASF1B, SDCCAG3, ASNS, PDCD2L) modules. The findings of the current study will help to improve our understanding of CRC. Moreover, the hub genes that we have identified could be considered as possible prognostic/diagnostic biomarkers. This study led to the determination of nine lncRNAs with no previous association with CRC development.

Highlights

  • Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, which after breast, lung and, prostate cancers, is the fourth prevalent cancer in the United States

  • Microarray gene expression data of colorectal cancer with the series number GSE106582 was obtained from the publicly available Gene Expression Omnibus (GEO) database to identify Long non-coding RNAs (lncRNAs) candidates .GSE106582 was provided by the University clinics Freiburg (Freiburg, Germany), and CRC patients were recruited at the University Hospital of Heidelberg

  • LncRNA expression data analysis of the GSE106582 dataset resulted in the identification of 32 differentially expressed lncRNAs (DELs) (Supplementary File 1), among which nine lncRNAs are detected as novel lncRNAs with no previous association with CRC development, including LINC01018, SNHG32, ITCH-IT1, ITPK1-AS1, FOXP1-IT1, FAM238B, PAXIP1DT, ATP2B1-AS1, and MIR29B2CHG (Table 1)

Read more

Summary

Introduction

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, which after breast, lung and, prostate cancers, is the fourth prevalent cancer in the United States. Publicly available microarray gene expression data of colorectal cancer (GSE106582) was analyzed with the Limma, Geoquery, Biobase package. LncRNAs were recently identified as regulatory molecules with a length of more than 200 nucleotides They bear some resemblances with mRNAs, including a cap at the 5′ end, having more than one exon, being transcribed by RNA polymerase II (RNA pol II), and being located in the cytoplasm or the nucleus. Forrest et al identified more than 200 differentially expressed lncRNAs by analyzing RNA sequencing data from The Cancer Genome Atlas (TCGA) dataset. They concluded these lncRNAs regulate cell cycle genes and increase resistance to ­apoptosis[14]. In addition to CRC cells, lncRNAs with altered expression level has been reported in peripheral blood components such as serum or p­ lasma[16]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.